Cypherpunk Technologies Inc.
NASDAQ:CYPHA public privacy-technology company with a Zcash-focused digital-asset treasury and a clinical-stage biotechnology subsidiary. Following a $58.88 million private placement led by Winklevoss Capital, the company rebranded from Leap Therapeutics in November 2025. Cypherpunk has stated an objective of holding at least 5% of ZEC's circulating supply over time while investing in privacy-protecting technology.
Company facts reviewed July 14, 2026. SEC filings